Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 01, 2011 (Vol. 31, No. 1)

National Institute on Drug Abuse

  • Nice site design, includes lots of information
  • None

Yes, it’s true—there is much more to the National Institute on Drug Abuse’s website than the “don’t do drugs” pamphlets we all remember from middle school. In fact, there is a wealth of information on this site for researchers, from information about applying for funding, to information about clinical trials, to datasets for analysis. The list goes on and on. Likewise, medical and health professionals will find a list of resources tailored to their practices and their patients in a separate section of the website. One useful feature of the website for visitors with specific interests is the “drugs of abuse and related topics” tab, which allows one to browse all of the information on the site relevant to a particular drug. There is plenty to read and plenty to learn on this website that goes far beyond the common sense antidrug sentiments with which we are all familiar.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »